Description

Description

Gpride-M SR 1/500mg is a combination tablet manufactured by Sami Pharmaceuticals, containing Glimepiride and Metformin together, with the Metformin component formulated in a sustained-release, or SR, form. This combination brings together two different classes of diabetes medication to help patients achieve more comprehensive blood sugar control than either ingredient might provide on its own. Glimepiride belongs to a class known as sulfonylureas, working by stimulating the pancreas to release more insulin. Metformin, delivered here in its sustained-release form, works primarily by reducing the amount of glucose produced by the liver and improving the body’s sensitivity to insulin, with the SR formulation allowing the medication to be released gradually over time, which can help improve tolerability and allow for less frequent dosing compared to immediate-release Metformin. Each pack of Gpride-M SR contains 30 tablets, generally intended for once-daily use as part of a diabetes management plan established by a physician.

Ingredients

Each Gpride-M SR tablet contains two active pharmaceutical ingredients: Glimepiride at a strength of 1mg and Metformin at a strength of 500mg, with the Metformin component formulated using sustained-release technology. The tablet also includes standard pharmaceutical excipients, such as fillers, binding agents, and coating layers designed to support the controlled release of the Metformin component, without contributing to the medicine’s therapeutic effect.

Dosage Form

Gpride-M SR is formulated as a sustained-release oral tablet, combining 1mg of Glimepiride with 500mg of Metformin in each unit. The tablets are supplied with a total of 30 units per pack, intended for oral administration only.

Uses

Gpride-M SR is primarily used to help manage blood sugar levels in adults with type 2 diabetes who are not adequately controlled on a single diabetes medication, or in those for whom a doctor determines that combination therapy is an appropriate approach. By combining a sulfonylurea with sustained-release Metformin, this medicine offers a broader mechanism of blood sugar reduction, helping to lower the long-term risks associated with poorly controlled diabetes, including damage to the eyes, kidneys, nerves, and blood vessels. It may be used as part of a wider treatment plan that also includes dietary and lifestyle adjustments recommended by a healthcare provider.

How to Use

Gpride-M SR should be taken exactly as directed by a prescribing physician, typically once daily with the evening meal, as taking it with food helps reduce the likelihood of stomach upset and aligns the Glimepiride component with food intake to reduce hypoglycemia risk. The tablet must be swallowed whole with a glass of water and should never be crushed, split, or chewed, as doing so would disrupt the sustained-release mechanism of the Metformin component and could cause the medication to be released too quickly. Meals should not be skipped after taking this medication. Doses should not be skipped, and treatment should not be stopped suddenly without consulting a doctor. If a dose is missed, it should be taken as soon as remembered, unless the next dose is nearly due, in which case the missed dose should be skipped rather than doubled.

Side Effects

As a combination medicine, Gpride-M SR may cause side effects associated with either or both of its active ingredients. Low blood sugar, or hypoglycemia, is one of the most significant risks associated with the Glimepiride component, with symptoms including shakiness, sweating, dizziness, confusion, and hunger. Gastrointestinal symptoms such as nausea, diarrhea, and stomach discomfort are commonly linked to the Metformin component, though the sustained-release formulation is often associated with improved digestive tolerability compared to immediate-release Metformin. Some patients may also experience a metallic taste, headache, or weight gain over the course of treatment. In rare but serious cases, this medication has been associated with a condition called lactic acidosis, related to the Metformin component, which is a medical emergency requiring immediate attention, with symptoms such as unusual muscle pain, difficulty breathing, or severe tiredness warranting urgent medical evaluation. Patients should carry a fast-acting source of sugar in case of hypoglycemic symptoms and should report any unusual or severe side effects to their doctor.

Pregnancy & Breastfeeding

Women who are pregnant, planning to become pregnant, or breastfeeding should consult their doctor before using Gpride-M SR, as blood sugar management during these periods typically requires a different approach, with insulin commonly preferred during pregnancy due to its more predictable control. This medication should not be started or continued during pregnancy or breastfeeding without direct medical guidance.

Storage Instructions

Gpride-M SR tablets should be stored in a cool, dry place, away from direct sunlight and excessive humidity. It is best to keep the tablets in their original packaging until they are needed and to store them securely out of the reach of children and pets. Tablets should not be used after the expiry date printed on the packaging.

FAQs

Why is Metformin included in a sustained-release form in this tablet?
The sustained-release formulation allows the Metformin component to be released gradually over time, which can help reduce stomach-related side effects and allow for more convenient once-daily dosing compared to immediate-release versions.

Why can’t I crush or split this tablet?
Crushing or splitting the tablet disrupts the sustained-release mechanism of the Metformin component, which can cause the medication to be released too quickly and increase the risk of side effects.

What should I do if I experience symptoms of low blood sugar?
If you notice symptoms such as shakiness, sweating, or confusion, you should consume a fast-acting source of sugar immediately and inform your doctor, especially if symptoms occur frequently.

What is lactic acidosis, and why is it a concern with this medication?
Lactic acidosis is a rare but serious condition related to the Metformin component, where lactic acid builds up in the blood; symptoms such as unusual muscle pain, difficulty breathing, or severe tiredness should be reported to a doctor immediately.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.